Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
3.85
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.51 Insider Own29.92% Shs Outstand290.82M Perf Week5.77%
Market Cap1.13B Forward P/E- EPS next Y-0.51 Insider Trans0.00% Shs Float206.07M Perf Month6.06%
Income-146.90M PEG- EPS next Q-0.12 Inst Own38.59% Short Float9.58% Perf Quarter-22.22%
Sales35.79M P/S31.63 EPS this Y6.32% Inst Trans11.09% Short Ratio14.83 Perf Half Y-13.09%
Book/sh3.85 P/B1.00 EPS next Y-6.14% ROA-9.92% Short Interest19.75M Perf Year-45.16%
Cash/sh2.46 P/C1.57 EPS next 5Y10.00% ROE-12.56% 52W Range3.58 - 8.05 Perf YTD-32.57%
Dividend Est.- P/FCF- EPS past 5Y- ROI-12.26% 52W High-52.17% Beta0.43
Dividend TTM- Quick Ratio7.75 Sales past 5Y387.52% Gross Margin14.66% 52W Low7.54% ATR (14)0.21
Dividend Ex-Date- Current Ratio7.76 EPS Y/Y TTM-190.52% Oper. Margin-634.92% RSI (14)46.49 Volatility5.31% 5.62%
Employees586 Debt/Eq0.07 Sales Y/Y TTM-80.23% Profit Margin-410.47% Recom1.00 Target Price14.62
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q0.50% Payout- Rel Volume0.79 Prev Close3.85
Sales Surprise-7.23% EPS Surprise-11.55% Sales Q/Q-18.36% EarningsMay 07 AMC Avg Volume1.33M Price3.85
SMA200.13% SMA50-7.07% SMA200-19.60% Trades Volume1,047,334 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-22-24Upgrade The Benchmark Company Hold → Buy $9
Dec-05-23Initiated KeyBanc Capital Markets Overweight $6
Nov-06-23Downgrade The Benchmark Company Buy → Hold
Oct-13-23Resumed Piper Sandler Overweight $20
Feb-28-23Initiated Cowen Outperform
Dec-15-22Initiated Goldman Buy $30
Nov-16-22Initiated Truist Buy $29
Dec-21-21Initiated The Benchmark Company Buy $27
Nov-19-21Initiated Piper Sandler Overweight $33
Jan-05-21Initiated SVB Leerink Outperform $45
May-13-24 06:00AM
May-08-24 11:03AM
07:01AM
04:30AM
May-07-24 08:57PM
06:05PM Loading…
06:05PM
06:01PM
04:05PM
May-01-24 09:00AM
Apr-30-24 10:01AM
Apr-08-24 12:05PM
Apr-03-24 04:05PM
Mar-27-24 04:30PM
Mar-26-24 05:25PM
Mar-19-24 04:05PM
09:00AM Loading…
Mar-11-24 09:00AM
Mar-05-24 04:30PM
Feb-26-24 06:55AM
Feb-23-24 04:30PM
Feb-22-24 08:15PM
Feb-21-24 09:22AM
07:09AM
Feb-20-24 11:00PM
07:00PM
04:57PM
04:05PM
Jan-30-24 01:02PM
Jan-23-24 04:05PM
Jan-15-24 09:30AM
Jan-03-24 09:40AM
04:05PM Loading…
Dec-20-23 04:05PM
Dec-16-23 01:00PM
Dec-11-23 03:30PM
Nov-16-23 04:05PM
Nov-03-23 12:05PM
10:51AM
08:42AM
05:55AM
05:30AM
Nov-02-23 05:56PM
04:05PM
Nov-01-23 04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-11-23 04:05PM
Sep-29-23 12:43PM
Sep-27-23 09:00AM
Sep-20-23 05:02PM
Sep-14-23 07:03PM
Sep-13-23 09:00AM
Aug-31-23 10:12PM
07:37AM
Aug-19-23 10:44AM
Aug-04-23 10:23AM
01:00AM
Aug-03-23 05:35PM
04:05PM
Jul-26-23 01:17PM
Jul-25-23 09:55AM
Jul-24-23 04:05PM
Jul-08-23 08:43PM
Jul-06-23 04:05PM
Jun-17-23 09:52AM
May-30-23 06:50AM
May-29-23 04:05PM
May-27-23 08:43AM
May-24-23 02:32PM
01:56PM
01:30PM
01:10PM
May-14-23 02:57PM
May-06-23 08:03AM
May-05-23 10:13AM
12:30AM
May-04-23 05:15PM
Apr-27-23 10:02AM
Apr-24-23 07:46PM
Apr-17-23 09:10AM
Apr-13-23 05:50AM
Apr-11-23 07:31PM
04:05PM
Apr-06-23 04:05PM
Apr-05-23 01:40PM
Mar-22-23 03:26PM
09:00AM
Mar-14-23 04:30PM
Mar-12-23 08:09AM
Feb-23-23 04:05PM
Feb-21-23 10:30PM
05:45PM
04:05PM
Feb-02-23 02:19PM
Feb-01-23 04:05PM
Jan-24-23 04:05PM
08:48AM
Jan-23-23 11:00AM
Jan-19-23 07:00PM
11:59AM
Jan-12-23 04:55AM
Jan-05-23 09:09AM
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hansen Carl L. G.Chief Executive OfficerMay 26 '23Option Exercise2.7056,125151,538561,250May 30 01:14 PM
Thermopylae Holdings Ltd.10% OwnerMay 26 '23Buy6.52153,000997,72856,012,493May 26 02:50 PM
Booth AndrewChief Financial OfficerMay 26 '23Buy6.8514,50099,325153,000May 26 02:53 PM